Diabetes Mellitus, Type 2

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. — Anniston, Alabama, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. — Birmingham, Alabama, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. — Phoenix, Arizona, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. — Concord, California, United States

Not specified

• Bastyr Center for Natural Health — Seattle, Washington, United States

• Huandong Hospital — Shanghai, China

• Birmingham, Alabama, United States
• Northport, Alabama, United States
• Mesa, Arizona, United States
• Phoenix, Arizona, United States

• Site 3 — Marseille, France
• Site 1 — Nantes, France
• Site 2 — Tours, France

• Research site — Cuernavaca, Morelos, Mexico

• Medicine Division, Diabetology, Endocrinology and Metabolic Disease Unit, IRCCS San Raffaele — Milan, Italy

• University of California, San Francisco — San Francisco, California, United States

• Harborview Medical Center — Seattle, Washington, United States